docetaxel,sotorasib
amgen
['biomarker', 'codebreak 200', 'sotorasib']
 biomarker subgroup analyses of codebreak 200 trial. very relevant information: better signal for sotorasib efficacy if no-comutations in tp53, stk11, keap1 or notch1 and low plasma tumor burden. we now have a better image of the patients who do better on sotorasib #asco23 
Medical Oncology 🏥 Hospital General Universitario Gregorio Marañón⎪@myESMO Faculty 🫁 ⎪Power to the patients #endlungcancer #lcsm